Paper Details

  1. Home
  2. Paper Details

Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.

Author: AllainH, Bentué-FerrerD, BouhoursP, GandonM, Le BretonS, TarralA, TessierC

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Low doses of risperidone, but not low doses of lorazepam, did not disturb the cognitive functions in the elderly.
Paper Details　
Original Abstract of the Article :
RATIONALE: Dementia includes not only cognitive deficit but may also include psychiatric and behavioral symptoms. These psychological symptoms of dementia require specific treatment without deleterious effects on cognitive functions. OBJECTIVE: The aim of the present study was to assess the effects...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00213-002-1272-2

データ提供：米国国立医学図書館（NLM）

Risperidone: A Gentle Approach to Managing Behavioral Symptoms in Elderly Individuals

The field of geriatric psychiatry addresses the unique challenges of mental health in older adults. This research investigates the effects of risperidone, an antipsychotic medication, on psychomotor performances and cognitive functions in healthy elderly individuals. The study employs a randomized, double-blind, crossover trial to evaluate the impact of various doses of risperidone compared to placebo and lorazepam. The researchers found that risperidone, at low doses, did not significantly impair cognitive function, suggesting its potential for managing behavioral symptoms in the elderly without compromising cognitive abilities.

Risperidone: A Promising Treatment for Behavioral Symptoms in Elderly Individuals

The study's findings suggest that low doses of risperidone can be a valuable tool for managing behavioral symptoms in elderly individuals without compromising cognitive function. This information provides crucial insights for treating dementia and other conditions that may involve behavioral disturbances, ensuring optimal well-being for older adults.

Cognitive Health and Aging

Maintaining cognitive health as we age is crucial. Engaging in mentally stimulating activities, such as puzzles, reading, and social interaction, can help preserve cognitive function. Regular physical activity and a healthy diet are also essential for overall brain health. Consulting a healthcare professional for any concerns regarding cognitive function is vital for receiving appropriate support and guidance.

Dr.Camel's Conclusion

Just as a wise elder in the desert possesses a wealth of knowledge and experience, older adults deserve compassionate care that addresses their unique needs. This research sheds light on a potential solution for managing behavioral challenges in the elderly, ensuring that their later years are filled with dignity and well-being.

Date :
  1. Date Completed 2003-03-20
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

12459926

DOI: Digital Object Identifier

10.1007/s00213-002-1272-2

Related Literature

Article Analysis
・Effective treatment of dementia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.